Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Monster Worldwide, Inc. (NYSE:MWW), InvenSense Inc (NYSE:INVN), Dean Foods Co (NYSE:DF), Exelixis, Inc. (NASDAQ:EXEL)
Monster Worldwide, Inc. (NYSE:MWW) was a volume gainer of 3.05 million shares and the average volume of the stock remained 2.50 million shares. The stock opened the session at $6.96 and finished at the end of the day at $6.94 and the stock plunged -0.57%.The market capitalization of the stock remained 784.46 million. Monster Worldwide, Inc., together with its subsidiaries, provides online and mobile employment solutions worldwide. It offers customized solutions and technologies across a range of public and private sectors. The company was founded in 1967 and is headquartered in New York, New York.
Has MWW Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, InvenSense Inc (NYSE:INVN) exchanged 2.96 million shares and the average volume remained 2.02 million shares. The stock closed the session at $20.21 with the drop of -0.15%. InvenSense, Inc. designs, develops, markets, and sells micro-electro-mechanical system (MEMS) gyroscopes for motion tracking devices in consumer electronics. The company was founded in 2003 and is headquartered in San Jose, California.
Why Should Investors Buy INVN After the Recent Fall? Just Go Here and Find Out
Dean Foods Co (NYSE:DF) decreased -3.90% and its closing price was $17.25. The volume of the stock was 2.93 million shares and the average volume remained 2.09 million shares. The market capitalization of the stock remained 1.63 billion. The beta of the stock remained 0.58. Dean Foods Company, a food and beverage company, processes and distributes milk, other fluid dairy products, and plant-based beverages. The company operates in two segments, Fresh Dairy Direct and WhiteWave. The company was founded in 1925 and is headquartered in Dallas, Texas.
Will DF Get Buyers Even After The Recent Rally? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) exchanged 2.92 million shares in the previous trading session, and its average trading remained 1.67 million shares. EXEL advanced 2.26% and it closed the trading at $7.00. The market capitalization of the stock remained 1.29 billion. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
For How Long EXEL’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)